Patents by Inventor Michael Macnamee

Michael Macnamee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF INDUCING OVULATION
    Publication number: 20060293222
    Abstract: The present invention relates to methods of inducing ovulation in a female host comprising the administration of a non-polypeptide cyclic adenosine monophosphate (cAMP) level modulator to the female host. In another aspect, the invention provides for specific administration of the phosphodiesterase inhibitor prior to the luteal phase of the host's ovulatory cycle. Preferred non-polypeptide cAMP level modulators include phosphodiesterase inhibitors, particularly inhibitors of phosphodiesterase 4 isoforms.
    Type: Application
    Filed: July 6, 2006
    Publication date: December 28, 2006
    Inventors: Stephen Palmer, Sean McKenna, Mark Tepper, Aliza Eshkol, Michael MacNamee
  • INHIBITORS OF PHOSPHODIESTERASES IN INFERTILITY
    Publication number: 20060229288
    Abstract: The present invention is directed to methods of increasing oocyte production in a mammal. More specifically, the specification describes methods and compositions for inducing follicular maturation using a PDE inhibitor. The inhibitor may be used alone at high doses. Alternatively, the follicular maturation is achieved by combining a low dose of FSH with the PDE inhibitor treatment.
    Type: Application
    Filed: February 28, 2006
    Publication date: October 12, 2006
    Inventors: STEPHEN PALMER, SEAN McKENNA, STEPHEN ARKINSTALL, ALIZA ESHKOL, MICHAEL MacNAMEE
  • Methods of inducing ovulation
    Publication number: 20060003925
    Abstract: The present invention relates to methods of inducing ovulation in a female host comprising the administration of a non-polypeptide cyclic adenosine monophosphate (cAMP) level modulator to the female host. In another aspect, the invention provides for specific administration of the phosphodiesterase inhibitor prior to the luteal phase of the host's ovulatory cycle. Preferred non-polypeptide cAMP level modulators include phosphodiesterase inhibitors, particularly inhibitors of phosphodiesterase 4 isoforms.
    Type: Application
    Filed: June 28, 2005
    Publication date: January 5, 2006
    Inventors: Stephen Palmer, Sean McKenna, Mark Tepper, Aliza Eshkol, Michael MacNamee
  • Methods of inducing ovulation using a non-polypeptide camp level modulator
    Publication number: 20050148501
    Abstract: The present invention relates to methods of inducing ovulation in a female host comprising the administration of a non-polypeptide cyclic adenosine monophosphate (cAMP) level modulator to female host. In another aspect, the invention provides for specific administration of the phosphodiesterase inhibitor prior to the luteal phase of the host's ovulatory cycle. Preferred non-polypeptide cAMP level modulator include phosphodiesterase inhibitors, particularly inhibitors of phosphodiesterase 4 isoforms.
    Type: Application
    Filed: December 14, 2001
    Publication date: July 7, 2005
    Inventors: Stephen Palmer, Mark Tepper, Sean Mckenna, Michael Macnamee, Aliza Eshkol
  • Use of aspirin for the manufacture of a medicament for implanting an embryo into the uterine endometrium
    Patent number: 6100249
    Abstract: The invention provides the use of a cycloaygenase inhibitor such as the non-steroidal anti-inflammatory agent aspirin in the manufacture of a medicament to enhance perfusion of blood through the mammalian, preferably human, uterus.
    Type: Grant
    Filed: December 5, 1997
    Date of Patent: August 8, 2000
    Assignee: Applied Research Systems ARS Holdings NV
    Inventor: Michael Macnamee
  • Method of using aspirin to implant an embryo
    Patent number: 5760024
    Abstract: The invention provides the use of a cyclooxygenase inhibitor such as the non-steroidal anti-inflammatory agent aspirin in the manufacture of a medicament to enhance perfusion of blood through the mammalian, preferably human, uterus. The enhanced perfusion aids embryo implantation in natural or assisted methods of conception.
    Type: Grant
    Filed: June 23, 1995
    Date of Patent: June 2, 1998
    Assignee: Applied Research Systems ARS Holding N.V.
    Inventor: Michael Macnamee